NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,195 | -95.2% | 10,500 | -90.8% | 0.00% | -100.0% |
| Q4 2022 | $570,272 | -94.6% | 113,600 | -86.0% | 0.00% | -90.5% |
| Q3 2022 | $10,613,334 | +2.9% | 811,366 | +0.8% | 0.02% | +10.5% |
| Q2 2022 | $10,318,319 | -17.5% | 804,886 | -1.9% | 0.02% | +5.6% |
| Q1 2022 | $12,513,587 | +72.2% | 820,536 | +100.0% | 0.02% | -5.3% |
| Q4 2021 | $7,266,000 | -14.7% | 410,264 | +1.2% | 0.02% | -20.8% |
| Q3 2021 | $8,521,000 | -26.1% | 405,367 | -30.7% | 0.02% | +41.2% |
| Q2 2021 | $11,534,000 | – | 584,882 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |